ABEV NYSE Week ended 31 Jul 2026

Weekly Investor Report

Ambev SA ADR · Consumer Defensive · Beverages - Brewers

Open interactive chart View report data
Latest close 3.11 USD
1.6% latest week
Weekly setup

Constructive, but selective

The weekly trend is active. Price is 3.6% above the Trend Line and sits at 77.3% of its 52-week range. The latest completed week returned 1.6%, after a 0.3% four-week move. The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers. Options positioning is volatility with 45/100 conviction, while the latest news-sentiment score is 54/100.

Setup score 54 out of 100
Latest Close 3.11 USD 31 Jul 2026
1W Return 1.6% latest completed week
4W Return 0.3% short-term follow-through
12W Return -5.2% quarterly tape
Trend Breadth 67.3% 35 of 52 weeks active
Volume Ratio 1.4x vs 13-week average
What is working
  • The trend backdrop is active with a 34-week active streak.
  • Price is above the Trend Line, keeping the weekly tape constructive.
  • Price is above Fair Value, showing premium demand versus the model.
  • Activity pressure is constructive, supporting the smart-money activity read.
What could go wrong
  • Activity pressure is negative, which weakens the current setup.
  • 1 reversal markers appear in the recent smart-money tape.
What to watch next
  • Trend Line remains the key weekly regime level.
  • Activity pressure is the gauge to monitor for confirmation or fade.
  • A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through 1.6% Latest completed week; four-week move 0.3%. Indicator stack 82/2 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. Options pressure Volatility 45/100 conviction; expected move 19.6%. News sentiment 54/100 48 relevant articles in the latest sentiment read. Event risk 30 Jul Latest stored earnings date was 30 Jul 2026.
01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 3.6% above the Trend Line and sits at 77.3% of its 52-week range. The latest completed week returned 1.6%, after a 0.3% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value
Price Trend Line Fair Value
02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 1.4x the 13-week average. Participation is around or above normal and provides reasonable confirmation.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction
6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul
Up week Down week
Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.6112-week average 0.72

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure1/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.61Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers11 reversal markers

No recent accumulation markers. 1 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 0.3% over four weeks, -5.2% over 12 weeks, and 52.5% over one year. The current trend has remained active for 34 consecutive weeks.

Performance by holding period

1W1.6%
4W0.3%
12W-5.2%
26W11.9%
52W52.5%
Active trend streak34 weeks
Active weeks in one year35
Trend breadth67.3%

Activity pressure vs relative leadership

Activity pressureRelative leadership
Pressure-0.74Latest activity-pressure read.
Pressure change-427.5%Four-week change in activity pressure.
Leadership7.49Latest relative-leadership reading.
RS change-14.9%Four-week change in relative leadership.
04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

The latest factor snapshot indicates quality ranks strongly versus its universe; growth ranks weakly; valuation is inexpensive relative to peers.

Open full factor analysis
Factor week 26 Jul 2026 Financial statements through 31 Mar 2026 Field coverage 100% Model confidence 96%

Relative factor standing

Higher display scores are better. Each score is converted from the underlying universe rank, where rank 1 is best.

Overall factor strength100/100Blend of value, momentum, and quality. Underlying universe rank 1; rank 1 is best.
Value99/100Relative valuation strength. Underlying universe rank 2; rank 1 is best.
Quality99/100Profitability and accounting quality. Underlying universe rank 2; rank 1 is best.
Momentum82/100Medium-term price momentum. Underlying universe rank 19; rank 1 is best.
Growth10/100Revenue and earnings growth. Underlying universe rank 91; rank 1 is best.
How to read this

Quality and valuation are separate questions

A strong company can still carry a demanding valuation. This report shows profitability, growth, balance-sheet strength, and the price paid for those characteristics separately.

Valuation

How much investors are paying for earnings, sales, and cash flow.

P/E
3.0x
Price divided by trailing earnings.
Price / sales
0.5x
Market value relative to trailing revenue.
EV / EBITDA
1.1x
Enterprise value relative to operating cash earnings.
Free-cash-flow yield
92.5%
Free cash flow as a share of enterprise value.

Business quality

Margins and the return generated on invested capital.

Gross margin
51.5%
Gross profit retained from each unit of revenue.
Operating margin
25.2%
Operating profit retained from revenue.
Free-cash-flow margin
34.7%
Free cash flow generated from revenue.
Return on invested capital
24.4%
Operating return generated on invested capital.

Growth and financial strength

Recent business growth and accounting strength.

Revenue growth
-3.8%
Latest one-year revenue growth.
EPS growth
7.9%
Latest one-year earnings-per-share growth.
Free-cash-flow growth
-1.7%
Latest one-year free-cash-flow growth.
Piotroski F-score
8/9
Nine-point accounting-strength checklist.

Shareholder return and balance sheet

Cash returned to owners and financial leverage.

Dividend yield
1.0%
Cash dividends relative to market value.
Buyback yield
2.7%
Net share repurchases relative to market value.
Shareholder yield
3.8%
Dividend yield plus net buyback yield.
Net debt / EBITDA
-0.5x
Balance-sheet debt relative to operating cash earnings.
05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Options positioningVolatility

ABEV shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 0.40, expected move of 19.6%, and Sharemaestro trend signal active.

Conviction45/100
Expected move19.6%
Put/call volume0.40
Pressure52
Speculation14
Volatility96
Trend agreement42
Open options detail
Insider activity-

No recent insider transactions are stored for this company.

News sentiment54/100

Weighted news tone is neutral across 48 relevant articles.

16 positive · 29 neutral · 3 negative
Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal
06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings30 JulLatest stored earnings date was 30 Jul 2026.
Options expected move19.6%Nearest-chain priced movement where available.
52-week drawdown-9.6%Distance below the 52-week high.
13-week volatility4.9%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

Weeks higher14 of 2612 weeks finished lower.
Best week+13.4%Week of 8 May.
Worst week-7.6%Week of 6 Mar.
Latest week+1.6%Week of 31 Jul.

Shape of recent returns

Strong gains7
Modest gains7
Flat weeks0
Modest losses6
Sharp losses6
Recent vol4.9%13-week weekly-return volatility.
Base vol4.2%52-week weekly-return volatility.
Up/down split29/20Count of positive and negative weeks in the 52-week window.
Average skew4.0% / -3.4%Average positive week versus average negative week.
07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape55/100

Trend, activity pressure, participation, and risk combine to a 55/100 tape read.

 Indicator analysis63/100

Latest 12-week confirmation: trend 12/12, activity pressure 1/12, relative leadership 12/12.

Activity pressure 0.61; 1 reversal markers Factors95/100

O'Shaughnessy factor stack blends value, quality, momentum, and confidence.

Cornerstone Growth rank 29; Buyback Yield rank 19 Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Options46/100

ABEV shows volatility options pressure with a 45/100 conviction score, put-call volume ratio of 0.40, expected move of 19.6%, and Sharemaestro trend signal active.

Volatility · Volatility expansion watch · Expected move 19.6% Sentiment54/100

Weighted news tone is neutral across 48 relevant articles.

Ambev (NYSE:ABEV) Director Ricardo Manuel Frangat Moreira Sells 468,040 Shares of Stock Insiders50/100

No recent insider transaction evidence is stored.

 Earnings30 Jul

Latest stored earnings date was 30 Jul 2026.
WeekCloseReturnTrend LineFair ValuePressureLeadershipVolumeTrend
31 Jul 20263.11 USD1.6%3.00 USD2.28 USD-0.747.49184.0MOn
24 Jul 20263.06 USD1.0%2.98 USD2.28 USD-0.927.3784.2MOn
17 Jul 20263.03 USD-1.3%2.96 USD2.27 USD-0.616.01101.7MOn
10 Jul 20263.07 USD-1.0%2.94 USD2.27 USD-0.396.03132.1MOn
3 Jul 20263.10 USD-4.0%2.91 USD2.27 USD-0.148.8087.0MOn
26 Jun 20263.23 USD3.8%2.89 USD2.26 USD-0.0216.07126.2MOn
19 Jun 20263.11 USD-4.0%2.86 USD2.26 USD-0.099.57120.5MOn
12 Jun 20263.24 USD4.2%2.83 USD2.25 USD-0.0115.41131.0MOn
5 Jun 20263.11 USD-2.8%2.81 USD2.25 USD-0.1811.71125.1MOn
29 May 20263.20 USD0.3%2.78 USD2.25 USD0.0312.22133.5MOn
22 May 20263.19 USD4.2%2.75 USD2.24 USD-0.1813.67154.9MOn
15 May 20263.06 USD-6.7%2.71 USD2.24 USD-0.3110.10121.9MOn
8 May 20263.28 USD13.4%2.68 USD2.23 USD-0.2118.31223.4MOn
1 May 20262.89 USD0.7%2.63 USD2.23 USD-0.196.8787.4MOn
How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.